
Global & Italy Cancer Therapeutics Market to 2031
Description
Italy has seen a steady rise in cancer cases in recent years. Based on GLOBOCAN data from the World Health Organization, approximately 430,000 new cancer cases were reported in the country in 2022, with breast cancer being the most frequently diagnosed, accounting for 13.2% of all cases. This was followed by colorectal cancer at 12.6% and lung cancer at 10.0%. That same year, cancer-related deaths reached around 190,000. Contributing to this trend is Italy’s aging population, which continues to grow due to declining birth rates and improved longevity. According to Eurostat’s 2024 data, Italy holds the distinction of having the oldest population in the European Union, with a median age exceeding 48 years. Nearly 24% of the population is over the age of 65—equivalent to roughly one in four citizens—and 7.7% are aged 80 or older. This demographic shift has led to a growing need for cancer treatments, particularly for age-related cancers such as breast, prostate, and lung cancer.
Italy's well-established healthcare infrastructure, coupled with increasing investments in medical research and healthcare spending, is expected to create significant growth opportunities in the cancer therapeutics sector. According to Knoema data, Italy’s healthcare expenditure per capita was $3,351 in 2021. This financial commitment supports the development and implementation of advanced cancer treatments, improving patient access to innovative therapies and driving overall market expansion.
Italy's well-established healthcare infrastructure, coupled with increasing investments in medical research and healthcare spending, is expected to create significant growth opportunities in the cancer therapeutics sector. According to Knoema data, Italy’s healthcare expenditure per capita was $3,351 in 2021. This financial commitment supports the development and implementation of advanced cancer treatments, improving patient access to innovative therapies and driving overall market expansion.
Table of Contents
100 Pages
- 1. Introduction
- 1.1 Report Guidance
- 1.2 Market Segmentation
- 2. Executive Summary
- 2.1 Key Insights
- 3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Data Triangulation and Validation:
- 4. Italy Cancer Therapeutics Market Landscape
- 4.1 Overview
- 4.2 Ecosystem Analysis
- 4.2.1 List of Vendors in the Value Chain
- 5. Cancer Therapeutics Market Key Market Dynamics
- 5.1 Cancer Therapeutics Market – Key Market Dynamics
- 5.2 Market Drivers
- 5.3 Market Restraints
- 5.4 Market Opportunities
- 5.5 Future Trends
- 5.6 Impact of Drivers and Restraints
- 6. Italy Cancer Therapeutics Market – Analysis
- 6.1 Italy Cancer Therapeutics Market Revenue (US$ Million), 2021–2031
- 6.2 Italy Cancer Therapeutics Market Revenue and Forecast Analysis
- 7. Italy Cancer Therapeutics Market Analysis – by Therapy Types
- 7.1 Italy Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Therapy Types
- 8. Italy Cancer Therapeutics Market Analysis – by Indications
- 8.1 Italy Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Indications
- 9. Italy Cancer Therapeutics Market Analysis – by Distribution Channel
- 9.1 Italy Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Distribution Channel
- 10. Competitive Landscape
- 10.1 Heat Map Analysis by Key Players
- 10.1 Company Positioning and Concentration
- 11. Industry Landscape
- 11.1 Overview
- 11.2 Market Initiative
- 11.2 Partnerships and Collaborations
- 11.2 Other Developments
- 12. Company Profiles
- 12.1 Bristol-Myers Squibb Co
- 12.1. 1 Key Facts
- 12.1. 2 Business Description
- 12.1. 3 Products and Services
- 12.1. 4 Financial Overview
- 12.1. 5 SWOT Analysis
- 12.1. 6 Key Developments
- 12.2 AbbVie Inc
- 12.2. 1 Key Facts
- 12.2. 2 Business Description
- 12.2. 3 Products and Services
- 12.2. 4 Financial Overview
- 12.2. 5 SWOT Analysis
- 12.2. 6 Key Developments
- 12.3 Johnson & Johnson
- 12.3. 1 Key Facts
- 12.3. 2 Business Description
- 12.3. 3 Products and Services
- 12.3. 4 Financial Overview
- 12.3. 5 SWOT Analysis
- 12.3. 6 Key Developments
- 12.4 F. Hoffmann-La Roche Ltd
- 12.4. 1 Key Facts
- 12.4. 2 Business Description
- 12.4. 3 Products and Services
- 12.4. 4 Financial Overview
- 12.4. 5 SWOT Analysis
- 12.4. 6 Key Developments
- 12.5 Pfizer Inc
- 12.5. 1 Key Facts
- 12.5. 2 Business Description
- 12.5. 3 Products and Services
- 12.5. 4 Financial Overview
- 12.5. 5 SWOT Analysis
- 12.5. 6 Key Developments
- 12.6 AstraZeneca Plc
- 12.6. 1 Key Facts
- 12.6. 2 Business Description
- 12.6. 3 Products and Services
- 12.6. 4 Financial Overview
- 12.6. 5 SWOT Analysis
- 12.6. 6 Key Developments
- 12.7 Merck KGaA
- 12.7. 1 Key Facts
- 12.7. 2 Business Description
- 12.7. 3 Products and Services
- 12.7. 4 Financial Overview
- 12.7. 5 SWOT Analysis
- 12.7. 6 Key Developments
- 12.8 Novartis AG
- 12.8. 1 Key Facts
- 12.8. 2 Business Description
- 12.8. 3 Products and Services
- 12.8. 4 Financial Overview
- 12.8. 5 SWOT Analysis
- 12.8. 6 Key Developments
- 12.9 Astellas Pharma Inc
- 12.9. 1 Key Facts
- 12.9. 2 Business Description
- 12.9. 3 Products and Services
- 12.9. 4 Financial Overview
- 12.9. 5 SWOT Analysis
- 12.9. 6 Key Developments
- 12.10 Eli Lilly and Co
- 12.10. 1 Key Facts
- 12.10. 2 Business Description
- 12.10. 3 Products and Services
- 12.10. 4 Financial Overview
- 12.10. 5 SWOT Analysis
- 12.10. 6 Key Developments
- 13. Appendix
- 13.1 About Business Market Insights
- 13.2 List of Abbreviations
- TABLE OF TABLES
- Table 1. Italy Cancer Therapeutics Market Segmentation
- Table 2. List of Vendors
- Table 3. Italy Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million)
- Table 4. Italy Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million)
- Table 5. Italy Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Therapy Types
- Table 6. Italy Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy Types
- Table 7. Italy Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Indications
- Table 8. Italy Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
- Table 9. Italy Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel
- Table 10. Italy Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel
- Table 11. List of Abbreviations
- TABLE OF FIGURES
- Figure 1. Impact Analysis of Drivers and Restraints
- Figure 2. Italy Cancer Therapeutics Market Revenue, (US$ Million), 2021–2031
- Figure 3. Heat Map Analysis by Key Players
- Figure 4. Company Positioning and Concentration
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.